It examines how core clock genes and tissue-specific circadian patterns influence drug action and absorption and summarizes evidence-based time-optimized interventions for hypertension, diabetes, dyslipidemia, obesity, and multimorbid patients. This evidence concerns the gene CLOCK and obesity due to melanocortin 4 receptor deficiency.